Navigation Links
Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
Date:4/28/2011

ooking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug, medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.  Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 as filed with the SEC on February 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequ
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ULURU Inc. Announces Commercial Exhibit and Scientific Presentations at the SAWC/WHS National Wound Symposium
2. HeartWare Announces Presentations at The International Society of Heart and Lung Transplantation Annual Meeting
3. WaferGen Announces Data Presentations From Newly Launched High-Throughput SmartChip Human microRNA Panel V2 at Scientific Conferences, Including AACR
4. Dendreon Announces Webcast Presentations at Upcoming Conferences
5. Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting
6. Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL)
7. Thoratec Announces Presentations at Upcoming Investor Conferences
8. Dehaier Medical Announces March Investor Presentations
9. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
10. Gen-Probe to Webcast Three Upcoming Investor Presentations
11. Regeneron Announces March 2011 Investor Conference Presentations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 2015  Seeger Weiss LLP is reporting that on July ... letter to C.R. Bard, the manufacturer of Inferior vena ... correct violations the agency found at two of Bard,s facilities. ... FDA cited them during Inspectional Observations that occurred on November ... Tempe, AZ , location and on October 6, 2014, ...
(Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
(Date:7/31/2015)... According to a new market research report " Sterilization ... Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, ... 2020", published by MarketsandMarkets, The Sterilization Equipment Market is expected ... CAGR of 7.6%.from 2015 to 2020. Browse ... and 37 F igures spread ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4
... NEW BRUNSWICK, N.J., Jan. 14, 2011 McNeil Consumer Healthcare ... JNJ ) company, in July 2010 submitted to the ... a commitment to restore its operations to the level of ... Johnson companies. As part of this commitment, McNeil undertook a ...
... 2011 New clinical research data suggests that [18F] ... by physicians and provide accurate identification of beta amyloid ... to Alzheimer,s Disease (AD).  Flutemetamol, a GE Healthcare Positron ... development, is being studied to identify the uptake of ...
Cached Medicine Technology:Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 3
(Date:7/31/2015)... GA (PRWEB) , ... July 31, 2015 , ... Girl ... stamp out bullying across Georgia through the Girl Scout "Be a Friend First" program. ... on Thursday, July 30. , “Peach State Health Plan and our parent company, ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The Mount Sinai ... research projects that evaluate the potential of related, experimental treatments. The collaboration moves into ... Health to award Columbia Care one of five state licenses to produce and dispense ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... BioViva USA, ... the way we treat aging diseases. , BioViva announces it has begun a ... patients with Alzheimer’s Disease (AD) and find a cure. MaxLife will grant 100% of ...
(Date:7/31/2015)... ... 2015 , ... Recently, ZKB filed another federal lawsuit in ... No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , As described in ... implants, inability to locate the implants, unsuccessful and invasive attempts at implant removal, ...
(Date:7/31/2015)... ... July 31, 2015 , ... The Heart Fit Clinic has ... angina until a heart rate of 150 beats versus 100 beats, this is a ... are able to give life back to patients with heart disease," he adds. People ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Heart Fit Clinic Helps Patient Increase Fitness Level with External Counterpulsation 2
... form "MaxLife-CGP",Partners LLC., a California based operation. "MaxLife-CGP" expects to ... face value, of which the Joint Venture anticipates ... ... /PRNewswire-FirstCall/ - MaxLife Fund Corp.,(OTC:MXFD). MaxLife Fund Corp. ("MaxLife") and ...
... Michael Aram,will lend his support to another noteworthy cause, The ... his flagship store on March,13th for a special benefit event., ... based charity that was,established in 1994, at a time when ... committed itself to raising awareness on and,preventing the local spread ...
... facility doubles US Phase I capacity, RALEIGH, N.C., ... has announced the grand opening of its,expanded, newly built ... the occasion with a special event at the facility ... Pharmacology Center,s size to 80,beds, with the clinic occupying ...
... Feb. 25 Weight Watchers,International, Inc. (NYSE: WTW ... Officer, and Ann Sardini, Chief Financial,Officer, will present at ... NY., The presentation will be held on Tuesday, ... be accessible via live audio webcast on the Company,s,website ...
... advocates have received the inaugural Omololu Falobi Award for ... awards honor the late Omololu Falobi, a long-time HIV ... Nigeria, was an instrumental pioneer member of the Nigerian ... & Microbicide Advocacy Group. Omololu was killed in ...
... LOS ANGELES, Feb. 25 Most Oscar pundits are ... Stars,",Michael Kosdon watched this year,s Academy Awards with a ... difference between bright, white camera-ready smiles and simply,adequate smiles ... Dr. Kosdon from his own Oscar party at The ...
Cached Medicine News:Health News:MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement 2Health News:MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement 3Health News:Weight Watchers to Present at Bank of America 2008 Consumer Conference 2Health News:Omololu Falobi Awards for Excellence in HIV Prevention Research Community Advocacy presented 2Health News:Omololu Falobi Awards for Excellence in HIV Prevention Research Community Advocacy presented 3
6 inch hand held occlcuder with 49 holes...
Designed to provide occlusion while permitting observation of the eye. Helpful to determine if only one eye is deviating. Approximately 9 inches long....
Short handle occluders are about 6 inches long....
Manual Lensmeter....
Medicine Products: